93 related articles for article (PubMed ID: 34111904)
1. The mechanistic analysis of founder virus data in challenge models.
Ortega-Villa AM; Nason MC; Follmann D
Stat Med; 2021 Sep; 40(20):4492-4504. PubMed ID: 34111904
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
3. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
[TBL] [Abstract][Full Text] [Related]
4. Surrogates of protection in repeated low-dose challenge experiments.
Long DM; Hudgens MG; Wu CD
Stat Med; 2015 May; 34(10):1747-60. PubMed ID: 25628249
[TBL] [Abstract][Full Text] [Related]
5. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.
Gardner MB
Antiviral Res; 1991 May; 15(4):267-86. PubMed ID: 1659310
[TBL] [Abstract][Full Text] [Related]
6. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
[TBL] [Abstract][Full Text] [Related]
7. Assessing vaccine effects in repeated low-dose challenge experiments.
Hudgens MG; Gilbert PB
Biometrics; 2009 Dec; 65(4):1223-32. PubMed ID: 19397589
[TBL] [Abstract][Full Text] [Related]
8. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
Kim CN; Adams DR; Bashirian S; Butera S; Folks TM; Otten RA
J Med Primatol; 2006 Aug; 35(4-5):210-6. PubMed ID: 16872284
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock.
Lopker M; Easlick J; Sterrett S; Decker JM; Barbian H; Learn G; Keele BF; Robinson JE; Li H; Hahn BH; Shaw GM; Bar KJ
J Virol; 2013 May; 87(10):5477-92. PubMed ID: 23468494
[TBL] [Abstract][Full Text] [Related]
10. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
[TBL] [Abstract][Full Text] [Related]
11. Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates.
McDermott AB; Mitchen J; Piaskowski S; De Souza I; Yant LJ; Stephany J; Furlott J; Watkins DI
J Virol; 2004 Mar; 78(6):3140-4. PubMed ID: 14990733
[TBL] [Abstract][Full Text] [Related]
12. Enhanced in vitro transcytosis of simian immunodeficiency virus mediated by vaccine-induced antibody predicts transmitted/founder strain number after rectal challenge.
Gupta S; Pegu P; Venzon DJ; Gach JS; Ma ZM; Landucci G; Miller CJ; Franchini G; Forthal DN
J Infect Dis; 2015 Jan; 211(1):45-52. PubMed ID: 24850790
[TBL] [Abstract][Full Text] [Related]
13. A discrete-time survival model with random effects for designing and analyzing repeated low-dose challenge experiments.
Kang C; Huang Y; Miller CJ
Biostatistics; 2015 Apr; 16(2):295-310. PubMed ID: 25190513
[TBL] [Abstract][Full Text] [Related]
14. Control of Heterologous Simian Immunodeficiency Virus SIV
Singh S; Ramírez-Salazar EG; Doueiri R; Valentin A; Rosati M; Hu X; Keele BF; Shen X; Tomaras GD; Ferrari G; LaBranche C; Montefiori DC; Das J; Alter G; Trinh HV; Hamlin C; Rao M; Dayton F; Bear J; Chowdhury B; Alicea C; Lifson JD; Broderick KE; Sardesai NY; Sivananthan SJ; Fox CB; Reed SG; Venzon DJ; Hirsch VM; Pavlakis GN; Felber BK
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793957
[TBL] [Abstract][Full Text] [Related]
15. Current advances in HIV vaccine preclinical studies using Macaque models.
Liang B; Li H; Li L; Omange RW; Hai Y; Luo M
Vaccine; 2019 Jun; 37(26):3388-3399. PubMed ID: 31088747
[TBL] [Abstract][Full Text] [Related]
16. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines.
Staprans SI; Feinberg MB
Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S5-32. PubMed ID: 15285703
[TBL] [Abstract][Full Text] [Related]
17. Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates.
Flatz L; Cheng C; Wang L; Foulds KE; Ko SY; Kong WP; Roychoudhuri R; Shi W; Bao S; Todd JP; Asmal M; Shen L; Donaldson M; Schmidt SD; Gall JG; Pinschewer DD; Letvin NL; Rao S; Mascola JR; Roederer M; Nabel GJ
J Virol; 2012 Aug; 86(15):7760-70. PubMed ID: 22593152
[TBL] [Abstract][Full Text] [Related]
18. Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses and challenge viruses. The European Concerted Action on 'Macaque Models for AIDS Research'.
Vaccine; 1995 Feb; 13(3):295-300. PubMed ID: 7631516
[TBL] [Abstract][Full Text] [Related]
19. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro.
Parren PW; Marx PA; Hessell AJ; Luckay A; Harouse J; Cheng-Mayer C; Moore JP; Burton DR
J Virol; 2001 Sep; 75(17):8340-7. PubMed ID: 11483779
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.
Sparger EE; Dubie RA; Shacklett BL; Cole KS; Chang WL; Luciw PA
Virology; 2008 May; 374(2):261-72. PubMed ID: 18261756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
